ClinicalTrials.gg
Not yet recruitingNCT07761637Updated Aug 12, 2026

Non-Wearable Audiovisual Distraction for Children's Medical Anxiety in the ED

An interventional study of Non-Wearable Audiovisual Distraction and Routine ED Care in Pediatric Anxiety, sponsored by National Taiwan University Hospital. Not yet recruiting at 1 site in Taiwan. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

Pediatric emergency department (ED) visits often cause significant anxiety and stress for young patients due to unfamiliar environments and invasive medical procedures. Non-pharmacological interventions, such as distraction, are vital for reducing pediatric anxiety and improving procedural outcomes.

This study evaluates the effectiveness of a non-wearable, immersive audiovisual distraction system (LG StanbyME display) in alleviating pediatric anxiety during emergency department care, compared to standard care.

The main questions it aims to answer are:

Does non-wearable audiovisual distraction reduce anxiety levels in pediatric emergency patients compared to standard care?

Does the intervention improve physiological indicators of distress, such as Heart Rate Variability (HRV)?

Participants will:

Be randomly assigned to either the non-wearable audiovisual distraction group or the routine care group.

Undergo continuous physiological monitoring (HRV) and clinical anxiety assessment (mYPAS-SF) during their ED visit.

Read the detailed description

Pediatric anxiety in emergency settings can lead to uncooperative behavior, prolonged procedure times, and long-term medical fear. Traditional Virtual Reality (VR) headsets often face clinical limitations in pediatric EDs, such as user discomfort, sanitation challenges, and restricted head/eye movement.

To address these barriers, this stratified randomized controlled trial (RCT) introduces a non-wearable, highly mobile immersive display system (LG StanbyME) combined with interactive soothing content and digital companionship.

Pediatric patients aged 3 to 12 years presenting to the Emergency Department of National Taiwan University Hospital Yunlin Branch will be screened for eligibility. Eligible participants will be randomized into two arms:

Experimental Group: Receives non-wearable immersive audiovisual distraction via the mobile display during ED waiting and procedural periods.

Control Group: Receives standard pediatric ED care without digital distraction devices.

Primary outcomes include objective autonomic nervous system activity evaluated through continuous Heart Rate Variability (HRV) monitoring using a wearable ECG recorder (QOCA ecg103). Secondary outcomes include subjective pediatric anxiety scores assessed via the Modified Yale Preoperative Anxiety Scale-Short Form (mYPAS-SF), parental anxiety, and staff satisfaction.

02

Conditions studied

  • Pediatric Anxiety

Keywords

  • Audiovisual Distraction
  • Pediatric Emergency Medicine
  • Heart Rate Variability
  • Non-Wearable Technology
  • mYPAS-SF
  • Procedural Pain and Anxiety
03

In context

Pain, Procedural

241 studies on the registry are indexed under Pain, Procedural; 64 are open to participants now.

This study's planned enrollment of 90 is close to the median of 90 across 227 interventional studies indexed under Pain, Procedural.

Browse Pain, Procedural studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,615 studies on the registry; 576 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pediatric patients aged 6 to 12 years presenting to the Emergency Department.
  • Requiring invasive medical procedures (e.g., blood sampling, intravenous line insertion, or laceration repair/suturing).
  • Patient and legal guardian/parent willing and able to provide informed assent/consent and comply with study protocols.

Exclusion criteria

Exclusion Criteria:

  • Patients with severe developmental delay, cognitive impairment, or neurological disorders affecting communication or behavioral assessment.
  • Patients with severe visual or hearing impairment that prevents interaction with the non-wearable display system.
  • Hemodynamically unstable patients or those requiring immediate life-saving resuscitation.
  • Patients with severe upper body or facial injuries that prevent the placement or operation of continuous recorders.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Audiovisual Distraction Group

    Pediatric patients receive non-wearable immersive audiovisual distraction via a mobile display (LG StanbyME presenting low-stimulation, guided soothing videos and simple interactive games) during emergency department procedures.

    Behavioral: Non-Wearable Audiovisual Distraction

  • Active comparator
    Routine Care Group

    Pediatric patients receive standard emergency department care without additional digital audiovisual distraction devices.

    Other: Routine ED Care

Interventions

  • BehavioralNon-Wearable Audiovisual Distraction

    Implementation of a non-wearable mobile display system (LG StanbyME) providing gentle, low-stimulation audiovisual distraction and digital companionship to alleviate pediatric procedural anxiety.

  • OtherRoutine ED Care

    Standard pediatric emergency department care according to clinical guidelines without digital distraction devices.

06

What researchers measure

Primary outcomes

  1. Changes in Heart Rate Variability High-Frequency Power (HF-HRV)

    Continuous measurement of parasympathetic autonomic activity evaluated via HF power in normalized units (nu) or $ms\^2$

    Time frame: Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).

  2. Changes in Heart Rate Variability LF/HF Ratio

    Autonomic nervous system balance assessed via the ratio of Low-Frequency to High-Frequency power.

    Time frame: Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).

  3. Changes in Heart Rate Variability RMSSD

    Short-term parasympathetic modulation evaluated via Root Mean Square of Successive Differences (RMSSD) in milliseconds (ms).

    Time frame: Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).

Secondary outcomes

  1. Pediatric Observational Anxiety Score (mYPAS-SF)

    Behavioral anxiety score assessed using the Modified Yale Preoperative Anxiety Scale-Short Form (mYPAS-SF). The tool evaluates 4 categories (activity, vocalization, emotional expressiveness, and state of arousal), yielding a total score ranging from 22.9 to 100, where higher scores indicate greater procedural anxiety.

    Time frame: Assessed at baseline (pre-procedure) and immediately post-procedure.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data, including demographic characteristics (age, sex), baseline and post-procedural mYPAS-SF scores, and time-domain/frequency-domain Heart Rate Variability (HRV) parameters (HF, LF/HF ratio, RMSSD), will be shared with qualified researchers upon reasonable request.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: Data will become available starting 6 months after publication of the primary manuscript and will remain available for up to 3 years

Access criteria: Data will be made available to qualified academic researchers for non-commercial scientific research. Requesters must submit a formal research proposal, sign a Data Use Agreement (DUA) to ensure participant confidentiality, and obtain approval from the Principal Investigator (Dr. Nai-Yun Chang)

Data sharing details ↗ · www.ylh.ntuh.gov.tw

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07761637
Collaborators
National Yunlin University of Science and Technology
Responsible party
Sponsor
First posted
Aug 12, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Aug 31, 2027 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Aug 12, 2026

Study contacts

Nai-Yun Chang, MD
Contact
gigi06060606@gmail.com
+886-972-655-205
Nai-Yun Chang, MD
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion